Wednesday, July 8, 2026

pharma · Hepatocellular Carcinoma · Hepatocellular Carcinoma (HCC) · TPST

Tempest Therapeutics

Tempest Therapeutics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Brisbane, USA HQ
14 Employees
Public company Type
TPST · NYSE Ticker
Company details
Status
Public
HQ
Brisbane, USA
Employees
14
Programs
3
Drugs
1
Patents
10
Intelligence · Clinical Trials

Tempest Therapeutics clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to Tempest Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Tempest Therapeutics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for Tempest Therapeutics.

  1. Part 1 TPST-1120 — Phase 1

    Clinical update
  2. TPST-1120 — Phase 3

    Clinical update
  3. TPST-1495 twice daily — Phase 1

    Clinical update

Trial registry

3 studies